Biosimilars for Rheumatoid Arthritis: Riding the 2023 Wave [Podcast]
Stanley B Cohen,1,* Mariah Z Leach2,* 1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA; 2Mamas Facing Forward, Louisville, Colorado, USA*These authors contributed equally to this workCorrespondence: Stanley B Cohen, Email s...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2023-10-01
|
| Series: | Open Access Rheumatology: Research and Reviews |
| Subjects: | |
| Online Access: | https://www.dovepress.com/biosimilars-for-rheumatoid-arthritis-riding-the-2023-wave-podcast-peer-reviewed-fulltext-article-OARRR |
| _version_ | 1797643761741725696 |
|---|---|
| author | Cohen SB Leach MZ |
| author_facet | Cohen SB Leach MZ |
| author_sort | Cohen SB |
| collection | DOAJ |
| description | Stanley B Cohen,1,* Mariah Z Leach2,* 1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA; 2Mamas Facing Forward, Louisville, Colorado, USA*These authors contributed equally to this workCorrespondence: Stanley B Cohen, Email scohen@dfwra.comAbstract: This article discusses some of the queries and concerns that patients may have about initiating or switching to treatment with a biosimilar for rheumatoid arthritis following the US 2023 release of several biosimilars of the adalimumab reference product, also known by the brand name, Humira. The article also covers the difference between a generic medicine and a biosimilar, and the clinical evidence to support the safety and efficacy of adalimumab biosimilars in patients with rheumatoid arthritis.Keywords: biosimilars, interchangeability, rheumatoid arthritis |
| first_indexed | 2024-03-11T14:20:42Z |
| format | Article |
| id | doaj.art-bf479c7ef5d540f1a768b389106fb056 |
| institution | Directory Open Access Journal |
| issn | 1179-156X |
| language | English |
| last_indexed | 2024-03-11T14:20:42Z |
| publishDate | 2023-10-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Open Access Rheumatology: Research and Reviews |
| spelling | doaj.art-bf479c7ef5d540f1a768b389106fb0562023-10-31T17:33:54ZengDove Medical PressOpen Access Rheumatology: Research and Reviews1179-156X2023-10-01Volume 1520721287766Biosimilars for Rheumatoid Arthritis: Riding the 2023 Wave [Podcast]Cohen SBLeach MZStanley B Cohen,1,* Mariah Z Leach2,* 1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA; 2Mamas Facing Forward, Louisville, Colorado, USA*These authors contributed equally to this workCorrespondence: Stanley B Cohen, Email scohen@dfwra.comAbstract: This article discusses some of the queries and concerns that patients may have about initiating or switching to treatment with a biosimilar for rheumatoid arthritis following the US 2023 release of several biosimilars of the adalimumab reference product, also known by the brand name, Humira. The article also covers the difference between a generic medicine and a biosimilar, and the clinical evidence to support the safety and efficacy of adalimumab biosimilars in patients with rheumatoid arthritis.Keywords: biosimilars, interchangeability, rheumatoid arthritishttps://www.dovepress.com/biosimilars-for-rheumatoid-arthritis-riding-the-2023-wave-podcast-peer-reviewed-fulltext-article-OARRRbiosimilarsinterchangeabilityrheumatoid arthritis |
| spellingShingle | Cohen SB Leach MZ Biosimilars for Rheumatoid Arthritis: Riding the 2023 Wave [Podcast] Open Access Rheumatology: Research and Reviews biosimilars interchangeability rheumatoid arthritis |
| title | Biosimilars for Rheumatoid Arthritis: Riding the 2023 Wave [Podcast] |
| title_full | Biosimilars for Rheumatoid Arthritis: Riding the 2023 Wave [Podcast] |
| title_fullStr | Biosimilars for Rheumatoid Arthritis: Riding the 2023 Wave [Podcast] |
| title_full_unstemmed | Biosimilars for Rheumatoid Arthritis: Riding the 2023 Wave [Podcast] |
| title_short | Biosimilars for Rheumatoid Arthritis: Riding the 2023 Wave [Podcast] |
| title_sort | biosimilars for rheumatoid arthritis riding the 2023 wave podcast |
| topic | biosimilars interchangeability rheumatoid arthritis |
| url | https://www.dovepress.com/biosimilars-for-rheumatoid-arthritis-riding-the-2023-wave-podcast-peer-reviewed-fulltext-article-OARRR |
| work_keys_str_mv | AT cohensb biosimilarsforrheumatoidarthritisridingthe2023wavepodcast AT leachmz biosimilarsforrheumatoidarthritisridingthe2023wavepodcast |